In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against organisms other than staphylococci
- PMID: 11897599
- PMCID: PMC127083
- DOI: 10.1128/AAC.46.4.1108-1111.2002
In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against organisms other than staphylococci
Abstract
BMS-247243, a novel cephalosporin inhibitory for methicillin-resistant staphylococci, primarily has activity against gram-positive bacteria. The activities of BMS-247243, cefotaxime, and ceftriaxone against streptococci and Streptococcus pneumoniae were similar. BMS-247243 inhibits Enterococcus faecalis but not Enterococcus faecium. BMS-247243 also inhibits many inherently vancomycin-resistant species (Leuconstoc, Lactobacillus, Pediococcus) and anaerobic gram-positive bacteria.
Figures
Similar articles
-
In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against methicillin-resistant and -susceptible staphylococci.Antimicrob Agents Chemother. 2002 Apr;46(4):971-6. doi: 10.1128/AAC.46.4.971-976.2002. Antimicrob Agents Chemother. 2002. PMID: 11897577 Free PMC article.
-
In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteria.Antimicrob Agents Chemother. 2001 May;45(5):1422-30. doi: 10.1128/AAC.45.5.1422-1430.2001. Antimicrob Agents Chemother. 2001. PMID: 11302805 Free PMC article.
-
In vivo antibacterial activity of RWJ-54428, a new cephalosporin with activity against gram-positive bacteria.Antimicrob Agents Chemother. 2003 Jan;47(1):43-7. doi: 10.1128/AAC.47.1.43-47.2003. Antimicrob Agents Chemother. 2003. PMID: 12499167 Free PMC article.
-
In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.Clin Microbiol Infect. 2007 Jun;13 Suppl 2:17-24. doi: 10.1111/j.1469-0691.2007.01722.x. Clin Microbiol Infect. 2007. PMID: 17488372 Review.
-
Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds.Diagn Microbiol Infect Dis. 1999 Feb;33(2):101-12. doi: 10.1016/s0732-8893(98)00108-4. Diagn Microbiol Infect Dis. 1999. PMID: 10091033 Review.
References
-
- Chalkley, L., C. Schuster, E. Potgieter, and R. Hakenbeck. 1991. Relatedness between Streptococcus pneumoniae and viridans streptococci: transfer of penicillin resistance determinants and immunological similarities of pencillin-binding proteins. FEMS Microbiol. Lett. 69:35-42. - PubMed
-
- Fung-Tomc, J., J. Clark, B. Minassian, M. Pucci, Y.-H. Tsai, E. Gradelski, L. Lamb, I. Medina, E. Huczko, B. Kolek, S. Chaniewski, C. Ferraro, T. Washo, and D. P. Bonner. 2002. In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against methicillin-resistant and -susceptible staphylococci. Antimicrob. Agents Chemother. 46:971-976. - PMC - PubMed
-
- National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS document M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
-
- National Committee for Clinical Laboratory Standards. 2000. Methods for antimicrobial susceptibility testing of anaerobic bacteria. NCCLS document M11-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
-
- Pfaller, M. A., R. N. Jones, G. V. Doern, K. Kugler, and the SENRY Participant Group. 1998. Bacterial pathogens isolated from patients with bloodstream infection; frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob. Agents Chemother. 42:1762-1770. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources